Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration

  1. Bossuyt, V.
  2. Provenzano, E.
  3. Symmans, W.F.
  4. Boughey, J.C.
  5. Coles, C.
  6. Curigliano, G.
  7. Dixon, J.M.
  8. Esserman, L.J.
  9. Fastner, G.
  10. Kuehn, T.
  11. Peintinger, F.
  12. Von Minckwitz, G.
  13. White, J.
  14. Yang, W.
  15. Badve, S.
  16. Denkert, C.
  17. MacGrogan, G.
  18. Penault-Llorca, F.
  19. Viale, G.
  20. Cameron, D.
  21. Davidson, N.E.
  22. Piccart, M.
  23. Norton, L.
  24. Earl, H.
  25. Alba, E.
  26. Lluch, A.
  27. Albanell, J.
  28. Amos, K.
  29. Becette, V.
  30. Biernat, W.
  31. Bonnefoi, H.
  32. Buzdar, A.
  33. Cane, P.
  34. Pinder, S.
  35. Carson, L.
  36. Dickson-Witmer, D.
  37. Gong, G.
  38. Green, J.
  39. Hsu, C.-Y.
  40. Tseng, L.-M.
  41. Kroep, J.
  42. Marilyn Leitch, A.
  43. Sarode, V.
  44. Mamounas, E.
  45. Marcom, P.K.
  46. Nuciforo, P.
  47. Paik, S.
  48. Peg, V.
  49. Peston, D.
  50. Pierga, J.-Y.
  51. Quintela-Fandino, M.
  52. Salgado, R.
  53. Sikov, W.
  54. Thomas, J.
  55. Unzeitig, G.
  56. Wesseling, J.
  57. Wilt, M.
  58. Show all authors +
Journal:
Annals of Oncology

ISSN: 1569-8041 0923-7534

Year of publication: 2015

Volume: 26

Issue: 7

Pages: 1280-1291

Type: Article

DOI: 10.1093/ANNONC/MDV161 GOOGLE SCHOLAR lock_openOpen access editor